ARYL AMIDINES - A NEW CLASS OF POTENT ORALLY-ACTIVE LEUKOTRIENE-B4 ANTAGONIST

被引：0

作者：

MAIN, AJ ^{[1
]}

BARSKY, LI ^{[1
]}

MORRISSEY, M ^{[1
]}

CADILLA, R ^{[1
]}

BOEHM, C ^{[1
]}

ZHANG, YC ^{[1
]}

SUH, HS ^{[1
]}

BOXER, JB ^{[1
]}

POWERS, DB ^{[1
]}

FUJIMOTO, RA ^{[1
]}

DOTI, RA ^{[1
]}

HEALY, CT ^{[1
]}

SELIGMANN, BE ^{[1
]}

UZIELFUSI, S ^{[1
]}

JARVIS, MF ^{[1
]}

SILLS, MA ^{[1
]}

JACKSON, RH ^{[1
]}

LIPSON, KE ^{[1
]}

CHIN, MH ^{[1
]}

PELLAS, TC ^{[1
]}

PASTOR, G ^{[1
]}

FRYER, LR ^{[1
]}

RAYCHAUDHURI, AA ^{[1
]}

KOTYUK, BL ^{[1
]}

机构：

[1] CIBA GEIGY CORP,DIV PHARMACEUT,RES DEPT,SUMMIT,NJ 07901

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1994年 / 207卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：3 / MEDI

共 50 条

[21] THE DISCOVERY OF L-749,329, A HIGHLY POTENT, ORALLY-ACTIVE ANTAGONIST OF ENDOTHELIN RECEPTORS
WALSH, TF
FITCH, KJ
CHAKRAVARTY, PK
WILLIAMS, DL
MURPHY, KA
NOLAN, NA
OBRIEN, JA
LIS, EV
PETTIBONE, DJ
KIVLIGHN, SD
GABEL, RA
ZINGARO, GJ
KRAUSE, SM
SIEGL, PKS
CLINESCHMIDT, BV
GREENLEE, WJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 145 - MEDI
[22] A potent, orally-active, long-acting bradykinin peptide antagonist for both B1 and B2 receptors
Stewart, JM
Gera, L
Whalley, ET
Hanson, WL
Zuzack, JS
FASEB JOURNAL, 1996, 10 (03): : 3273 - 3273
[23] PS-15 - A POTENT, ORALLY-ACTIVE ANTIMALARIAL FROM A NEW CLASS OF FOLIC-ACID ANTAGONISTS
CANFIELD, CJ
MILHOUS, WK
AGER, AL
ROSSAN, RN
SWEENEY, TR
LEWIS, NJ
JACOBUS, DP
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1993, 49 (01): : 121 - 126
[24] LEUKOTRIENE-B4 IS A POTENT AND STEREOSPECIFIC STIMULATOR OF NEUTROPHIL CHEMOTAXIS AND ADHERENCE
PALMBLAD, J
MALMSTEN, CL
UDEN, AM
RADMARK, O
ENGSTEDT, L
SAMUELSSON, B
BLOOD, 1981, 58 (03) : 658 - 661
[25] EFFECT OF A LEUKOTRIENE-B4 RECEPTOR ANTAGONIST ON LEUKOTRIENE-B4-INDUCED NEUTROPHIL CHEMOTAXIS IN CAVINE DERMIS
FRETLAND, DJ
WIDOMSKI, DL
ZEMAITIS, JM
DJURIC, SW
SHONE, RL
INFLAMMATION, 1989, 13 (05) : 601 - 605
[26] L-368,899, A POTENT ORALLY-ACTIVE OXYTOCIN ANTAGONIST FOR POTENTIAL USE IN PRETERM LABOR
PETTIBONE, DJ
CLINESCHMIDT, BV
GUIDOTTI, MT
LIS, EV
REISS, DR
WOYDEN, CJ
BOCK, MG
EVANS, BE
FREIDINGER, RM
HOBBS, DW
VEBER, DF
WILLIAMS, PD
CHIU, SHL
THOMPSON, KL
SCHORN, TW
SIEGL, PKS
KAUFMAN, MJ
CUKIERSKI, MA
HALUSKA, GJ
COOK, MJ
NOVY, MJ
DRUG DEVELOPMENT RESEARCH, 1993, 30 (03) : 129 - 142
[27] A POTENT, ORALLY-ACTIVE, BALANCED AFFINITY ANGIOTENSIN-II AT(1) ANTAGONIST AND AT(2) BINDING INHIBITOR
DELASZLO, SE
QUAGLIATO, CS
GREENLEE, WJ
PATCHETT, AA
CHANG, RSL
LOTTI, VJ
CHEN, TB
SCHECK, SA
FAUST, KA
KIVLIGHN, SS
SCHORN, TS
ZINGARO, GJ
SIEGL, PKS
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (21) : 3207 - 3210
[28] LR-B/057 - A NOVEL ORALLY-ACTIVE AT1 RECEPTOR ANTAGONIST
RENZETTI, AR
CUCCHI, P
GUELFI, M
SALIMBENI, A
SUBISSI, A
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 : P267 - P267
[29] PHARMACOLOGY OF LR-B/057, A NOVEL ORALLY-ACTIVE AT(1) RECEPTOR ANTAGONIST
RENZETTI, AR
CUCCHI, P
GUELFI, M
CIRILLO, R
SALIMBENI, A
SUBISSI, A
GIACHETTI, A
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (03) : 354 - 360
[30] SYNTHESIS OF AN ORALLY-ACTIVE PAF ANTAGONIST OF THE N-[4-(3-PYRIDINYL) BUTYL]PENTADIENAMIDE CLASS
MANCHAND, PS
SCHWARTZ, A
WOLFF, S
BELICA, PS
MADAN, P
PATEL, P
SAPOSNIK, SJ
HETEROCYCLES, 1993, 35 (02) : 1351 - 1369

← 1 2 3 4 5 →